| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/17/2008 | WO2008086025A2 Treatment of respiratory chain disorders using compounds having erythropoietin or thrombopoietin activity |
| 07/17/2008 | WO2008085982A2 Methods and compositions for treating hypoglycemic disorders |
| 07/17/2008 | WO2008085913A1 Methods for treating, preventing, or reducing the risk of opthalmic, otic, and nasal infections |
| 07/17/2008 | WO2008085912A1 Compositions of and methods of using sulfatases from flavobacterium heparinum |
| 07/17/2008 | WO2008085888A1 G protein-coupled receptor and modulators thereof for the treatment of gaba-related neurological disorders including sleep-related disorders |
| 07/17/2008 | WO2008085828A2 Peptide modulators of angiogenesis and use thereof |
| 07/17/2008 | WO2008085578A2 Anti-microbial compositions and devices and methods of using the same |
| 07/17/2008 | WO2008085563A1 Recombinant viral proteins and particles |
| 07/17/2008 | WO2008085494A1 Short bio-active peptides for cellular and immunological modulation |
| 07/17/2008 | WO2008085366A2 Methods and compositions for the killing of cells expressing human cd59 |
| 07/17/2008 | WO2008085191A1 Polypeptide inhibitors of hsp27 kinase and uses therefor |
| 07/17/2008 | WO2008084710A1 Inhibitor of herpesvirus infection, method for inhibition of herpesvirus infection, and use thereof |
| 07/17/2008 | WO2008084652A1 Vascular endothelial cell-binding peptide |
| 07/17/2008 | WO2008084483A1 Novel therapeutics based on tau/microtubule dynamics |
| 07/17/2008 | WO2008084478A2 Anti-bacterial peptides and methods of treating diseases using same |
| 07/17/2008 | WO2008084368A2 Non-immunosuppressive cyclosporin for treatment of ullrich congenital muscular dystrophy |
| 07/17/2008 | WO2008084268A1 Use of biglycan or enhancers of biglycan activity in the preparation of pharmaceutical compositions |
| 07/17/2008 | WO2008084237A2 Stabilization of aqueous compositions of proteins with displacement buffers |
| 07/17/2008 | WO2008084072A2 Protective proteins of s. agalactiae, combinations thereof and methods of using the same |
| 07/17/2008 | WO2008084051A1 Mixtures of pegylated insulin and fast acting insulin for pulmonary administration |
| 07/17/2008 | WO2008084040A1 Use of mage a3-protein d fusion antigen in immunotherapy combined with surgery, chemotherapy or radiotherapy for the treatment of cancer |
| 07/17/2008 | WO2008083678A2 Pharmaceutically active compounds |
| 07/17/2008 | WO2008083615A1 Complexes comprising angiostatin and its fragments, preparation preparing methods and uses thereof |
| 07/17/2008 | WO2008083543A1 Nitrogen-containing heterocyclic modified compounds and uses thereof |
| 07/17/2008 | WO2008063957A3 Cblb for treating endotoxin-mediated disorders |
| 07/17/2008 | WO2008062110A3 Cosmetic and/or pharmaceutical composition containing at least one peptide as the active ingredient and use of said peptide |
| 07/17/2008 | WO2008049011A3 Alpha-msh therapies for treatment of autoimmune disease |
| 07/17/2008 | WO2008024767A3 Method and composition for treating a fibrotic disorder |
| 07/17/2008 | WO2008024195A3 Methods and compositions for conserving and/or preparing an organ or tissue for transplant |
| 07/17/2008 | WO2007139941A3 Composition and methods for treatment of congestive heart failure |
| 07/17/2008 | WO2007137163A3 Abc transporter ligand |
| 07/17/2008 | WO2007130655A3 Phage derived antimicrobial activities |
| 07/17/2008 | WO2007117337A3 Development of novel antibiotic alternatives |
| 07/17/2008 | WO2007115571A3 Erbb receptor-derived peptide fragments |
| 07/17/2008 | WO2007081654B1 Compositions and methods to enhance viability and function of islet cells |
| 07/17/2008 | WO2007066109A8 Bispecific ligands with binding specificity to cell surface targets and methods of use therefor |
| 07/17/2008 | WO2007062483A8 Increasing pregnancy rates |
| 07/17/2008 | WO2006055743A3 Compbination growth therapy and cell therapy for treatment of acute and chronic diseases of the organs |
| 07/17/2008 | WO2005098449A3 Hausp-mdm2 interaction and uses thereof |
| 07/17/2008 | WO2001060998A9 Small oligonucleotides with anti-tumor activity |
| 07/17/2008 | US20080172751 Agent Comprising Fgf2 as an Effective Ingredient For Treatment or Prevention of Asthma and Chronic Obstructive Pulmonary Disease |
| 07/17/2008 | US20080171862 Double stranded RNA packaged in liposome for use therapeutic tool in treatment of cell proliferative and viral disorders; Antisense oligonucleotide for use in prevention and treatment of viral and tumor disorders; gene expression inhibition; RNA interference |
| 07/17/2008 | US20080171861 Method and medicament for inhibiting the expression of a given gene |
| 07/17/2008 | US20080171854 Tumor suppressor gene, p47ing3 |
| 07/17/2008 | US20080171853 Formed via solid-state chemistry with 4-methylbenzylhydrylamine functionalized crosslinked polystyrene resin; deblocking, deprotecting; methylation |
| 07/17/2008 | US20080171850 Isomeric mixture of a cyclosporine analogue modified at the 1-amino acid residue with a 1,3-diene substituent; antiinflammatory agents; autoimmune disease; side effect reduction; reduced toxicity |
| 07/17/2008 | US20080171714 Substances for preventing and treating autoimmune diseases |
| 07/17/2008 | US20080171713 Substances for preventing and treating autoimmune diseases |
| 07/17/2008 | US20080171705 Methods of inducing and treating vascular disease |
| 07/17/2008 | US20080171704 Composition and method for treating diabetes |
| 07/17/2008 | US20080171703 Method of administering and using VEGF inhibitors for the treatment of human cancer |
| 07/17/2008 | US20080171702 Novel gene and uses therefor |
| 07/17/2008 | US20080171701 Method for inhibiting new tissue growth in blood vessels in a patient subjected to blood vessel injury |
| 07/17/2008 | US20080171700 Use Of Secretagogue For The Teatment Of Ghrelin Deficiency |
| 07/17/2008 | US20080171699 [(N,N- epsilon -Dimethyl)-D-lysyl]8cyclosporine; hepatitis C viricide |
| 07/17/2008 | US20080171698 A tripeptide mimetic produced by solid phase synthesis on a modified polystrene resin; ACE inhibitors with prolonged activity, improved bioavailability and side effect reduction |
| 07/17/2008 | US20080171697 Mitochondriotoxic cyclic polypeptides that induce endocytolysis or angiogenesis in human endothelial cells expressing alpha V beta 3 receptors; anticarcinogenic agents for adenomas, melanomas, osteosarcomas, prostate, breast, colon, or pancreatic cancers; antiarthritici agents; diabetic retinopathy |
| 07/17/2008 | US20080171696 Pharmacodynamically enhanced therapeutic proteins |
| 07/17/2008 | US20080171695 Acylated with polyethylene glycol, polypropylene glycol or polybutylene glycol in combination with a fatty diacid; improved bioavailability, first pass effect, solubility at physiological pH values and prolonged pharmacokinetics |
| 07/17/2008 | US20080171694 Forming a suspension by combining an acidic solution of insulin, zinc chloride, protamine, phenol or m-cresol, glycerol as an isotonic agent, and sodium chloride with a basic solution of disodium phosphate, phenol or m-cresol, glycerol and sodium chloride; quick release as well as time-release action |
| 07/17/2008 | US20080171693 Such as Survivn; antiproliferative, antitumor agents; apoptosis; a polypeptide peptidomimetic that includes the amino acid sequence His-Ser-Ser-Gly-Cys |
| 07/17/2008 | US20080171692 Substituted amides |
| 07/17/2008 | US20080171691 Inhibition of invasive remodelling |
| 07/17/2008 | US20080171690 Compositions and methods for the therapy and diagnosis of lung cancer |
| 07/17/2008 | US20080171689 Having an extracellular domain of an FGFR1 polypeptide having an increased sialaytion level for more stability and a Fc fusion partner; antiproliferative, anticarcinogenic, antitumor agents; angiogenesis inhibitors; |
| 07/17/2008 | US20080171688 And for use in the serological diagnosis of Varicella-Zoster virus infections; lower risk than vaccines from attenuated viable viruses |
| 07/17/2008 | US20080171687 Compositions And Methods For The Preparation And Administration Of Poorly Water Soluble Drugs |
| 07/17/2008 | US20080171363 Interferon-alpha polypeptides and conjugates |
| 07/17/2008 | US20080171362 Polynucleotides Encoding Proteins with Clot-Specific Streptokinase Activity |
| 07/17/2008 | US20080171328 Vertebrate hedgehog polypeptide for use as tools in identifying modulators for use in treatment and prevention of nervous system disorders |
| 07/17/2008 | US20080171095 Strokes; antiischemic agents; administering carnosine dipeptide, homocarnosine, anserine, or ofidine; reduction of stroke symptoms such as weakness, paralysis, numbness, or tingling; slurred speech, drooling, swallowing problems; loss of memory; vertigo; mood or personality changes; vision defects |
| 07/17/2008 | US20080171094 Treatment of burns |
| 07/17/2008 | US20080171085 Novel biphasic delivery system for a pharmaceutical or nutraceutical composition and method of administration |
| 07/17/2008 | US20080171080 Methods of treating neurological conditions with hematopoeitic growth factors |
| 07/17/2008 | US20080171076 Dermatological and/or Cosmetic Composition Containing Polypeptides |
| 07/17/2008 | US20080171071 Novel IGF-1 composition and its use |
| 07/17/2008 | US20080171065 Methods of Treating Nerve Entrapment Syndromes |
| 07/17/2008 | US20080171060 Lymphocyte receptor peptide for use in prevention and treatment of viral infection, cell proliferative, cardiovascular and allergic disorders; enhancing cytokine production |
| 07/17/2008 | US20080171054 Immunoglobulin for use in detection, prevention and treatment of methicillin-resistant staphylococcus aureus (MRSA) infection |
| 07/17/2008 | US20080171052 Hmgb1 protein inhibitorsand/or antagonists for the treatment of vascular diseases |
| 07/17/2008 | US20080171051 Cancer Treatment |
| 07/17/2008 | US20080171050 Treatment of hyperproliferative diseases with epidermal growth factor receptor antagonists |
| 07/17/2008 | US20080171048 Compositions and methods for the therapy and diagnosis of lung cancer |
| 07/17/2008 | US20080171046 Novel proteins and nucleic acids encoding same |
| 07/17/2008 | US20080171041 Method for treating inflammation |
| 07/17/2008 | US20080171037 Tumor necrosis factor receptor ligand for use in identifying modulators for prevention and treatment of cell proliferative, nervous system, cardiovascular and autoimmune disorders |
| 07/17/2008 | US20080171035 Mammalian cell membrane proteins; related reagents |
| 07/17/2008 | US20080171034 2-Adamantyl-3-hydroxycyclopenta[a]phenanthren-17-yldeneimino-oxy, -amino- and -aminocarbonyl compounds; degenerative diseases including neurodegenerative; ophthalmic; cardiovascular; bone, joint, connective tissue or cartilage; & mitochondrial disorders; transplants; altered activity of excitotoxic path |
| 07/17/2008 | US20080171033 Dipeptidyl peptidase-4 (DPP-4) (CD26) for use in treating diabetic retinopathy, psoriasis and arthritis; cytokine inhibition of interleukin-1 activity |
| 07/17/2008 | US20080171032 Nutrient mixture comprising free radical quenchers for use in ameliorating or preventing detrimental effects of oxidative stress |
| 07/17/2008 | US20080171029 Beauty mask |
| 07/17/2008 | US20080171027 Compositions and Methods for Elimination of Unwanted Cells |
| 07/17/2008 | US20080171026 Using recombinant cells expressing measles virus H glycoprotein to target tumor cells fusion and removal; tissue target therapy |
| 07/17/2008 | US20080171021 Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation |
| 07/17/2008 | US20080171017 Therapeutic mixture comprising chimeric interleukin receptor, microbiocidal, antiproliferative and chemotherapeutic agent for use in treatment and prevention of infectious and cancer disorders |
| 07/17/2008 | US20080171016 Death Domain Containing Receptors |
| 07/17/2008 | US20080171015 Compounds for the Treatment of Hepatitis C |
| 07/17/2008 | US20080171014 Interleukin-13 binding proteins |
| 07/17/2008 | US20080170998 Preventing adhesion of Porphyromonas gingivalis as periodontopathic bacterium to oral tissue using oligo or polypeptide of arginine-histidine |
| 07/17/2008 | US20080170995 Buccal, polar and non-polar spray or capsule containing cardiovascular or renal drugs |